NYSE - Delayed Quote USD
Takeda Pharmaceutical Company Limited (TAK)
14.36
+0.09
+(0.63%)
At close: May 9 at 4:00:02 PM EDT
13.79
-0.57
(-3.97%)
Pre-Market: 5:21:26 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2026) | Next Year (2027) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in JPY | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2026) | Next Year (2027) |
|---|---|---|---|---|
| No. of Analysts | 3 | 2 | 12 | 15 |
| Avg. Estimate | 1.14T | 1.15T | 4.58T | 4.63T |
| Low Estimate | 1.13T | 1.13T | 4.5T | 4.34T |
| High Estimate | 1.16T | 1.18T | 4.72T | 4.83T |
| Year Ago Sales | 1.21T | 1.18T | 580.36B | 4.58T |
| Sales Growth (year/est) | -5.43% | -2.01% | 689.50% | 1.04% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2026) | Next Year (2027) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2026) | Next Year (2027) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| TAK | -- | -- | -- | -- |
| S&P 500 | 13.21% | 3.06% | 8.01% | 13.77% |
Upgrades & Downgrades
| Maintains | TD Cowen: Outperform to Outperform | 5/16/2023 |
| Maintains | TD Cowen: Outperform | 4/4/2023 |
| Upgrade | B of A Securities: Neutral to Buy | 3/16/2023 |
| Upgrade | Cowen & Co.: Market Perform to Outperform | 7/19/2022 |
| Downgrade | Morgan Stanley: Overweight to Equal-Weight | 10/7/2021 |
| Maintains | JP Morgan: Overweight | 3/11/2020 |
Related Tickers
HLN Haleon plc
10.74
+1.61%
RDY Dr. Reddy's Laboratories Limited
13.40
+1.67%
VTRS Viatris Inc.
8.77
-3.52%
ELAN Elanco Animal Health Incorporated
11.96
-2.61%
ALKS Alkermes plc
30.13
-0.82%
AMRX Amneal Pharmaceuticals, Inc.
7.41
-0.67%
UTHR United Therapeutics Corporation
301.42
-2.14%
PRGO Perrigo Company plc
27.01
+0.78%
ZTS Zoetis Inc.
159.27
-1.50%
NBIX Neurocrine Biosciences, Inc.
115.71
-1.54%